EC1023 — House Communication 116th Congress (2019-2020)
Congressional Record Date: 05/14/2019
Federal Rulemaking: R8070
Abstract: A letter from the Regulations Coordinator, Centers for Medicare and Medicaid Services, Department of Health and Human Services, transmitting the Department's Major final rule - Medicare and Medicaid Programs; Regulation To Require Drug Pricing Transparency [CMS-4187-F] (RIN: 0938-AT87) received May 10, 2019, pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868); jointly to the Committees on Energy and Commerce and Ways and Means.
Referred to Committee Date:
- 05/14/2019 — House Energy and Commerce
- 05/14/2019 — House Ways and Means
Requirement Number: R8070
Agency: Multiple Executive Agencies and Departments
NATURE: Congressional review of agency rulemaking.
Legal Authority: 5 U.S.C. 801(a)(1)(A); Public Law 104–121, section 251; (110 Stat. 868)